Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
The findings suggest that plasma sEVs contribute to systemic immune modulation in HNC by inducing dysfunctional T-cell phenotypes and underscores the need for further investigation into their relevance for immunotherapeutic strategies in HNC.